Sector#Biotechnology - Therapeutics
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the eye
- #Diseases of the nervous system
- #Endocrine - nutritional and metabolic diseases
Apitope focuses on immunotherapies for the treatment of autoimmune and allergic diseases, including multiple sclerosis, factor VIII intolerance, uveitis and Graves’ disease. Apitope has a discovery platform which enables the selection of highly specific disease-modifying peptide therapies. These therapies selectively reinstate immune tolerance to the disease target of interest. Apitope has generated a pipeline of 6 clinical and preclinical programmes. The lead programme is partnered with Merck Serono.